Halozyme Therapeutics, ein führendes Biopharma-Unternehmen, hat gestern mit einem beeindruckenden Quartalsbericht für Aufsehen gesorgt. Das Unternehmen verzeichnete im dritten Quartal…
Kulmbach (www.aktiencheck.de) - Halozyme Therapeutics- Aktienanalyse von "Der Aktionär":
Laut Michel Doepke vom Anlegermagazin "Der Aktionär" ist die Aktie von Halozyme…
…
…
…
…
…
…
…
…
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…
…
…
Halozyme (HALO) shares rise 4% in the after-market trading hours on better-than-expected second-quarter 2023 results, boosted by collaboration and royalty…
The headline numbers for Halozyme Therapeutics (HALO) give insight into how the company performed in the quarter ended June 2023,…
Halozyme Therapeutics (HALO) delivered earnings and revenue surprises of 17.46% and 9.47%, respectively, for the quarter ended June 2023. Do…
SAN DIEGO, July 25, 2023 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its second…
Halozyme Therapeutics (HALO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings…
Halozyme (HALO) rises 5% after Roches late-stage multiple sclerosis study of subcutaneous co-formulation of Ocrevus developed with its Enhanze technology…
Halozyme Therapeutics (HALO) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…
Halozyme (HALO) first-quarter earnings and revenues miss estimates. The company reiterates its guidance for 2023....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Revenue Increased 38% YOY to $162.1 million; GAAP Diluted Earnings per Share of $0.29 and Non-GAAP Diluted Earnings per Share…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
SAN DIEGO, April 25, 2023 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its first…
Halozyme Therapeutics (HALO) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…
Halozyme Therapeutics (HALO) saw its shares surge in the last session with trading volume being higher than average. The latest…
Latest Ratings for HALO
DateFirmActionFromTo Nov 2021Wells FargoMaintainsOverweight Nov 2021JMP SecuritiesMaintainsMarket Outperform Nov 2021SVB LeerinkMaintainsOutperform
…
Investors need to pay close attention to Halozyme Therapeutics (HALO) stock based on the movements in the options market lately....…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Halozyme Therapeutics (HALO) delivered earnings and revenue surprises of 2.13% and 2.46%, respectively, for the quarter ended December 2022. Do…
Investors need to pay close attention to Halozyme (HALO) stock based on the movements in the options market lately....…
Though Halozyme (HALO) expects a year-over-year increase in revenues and earnings for 2023, the companys guidance fell short of Wall…
SAN DIEGO, Jan. 11, 2023 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that it has elected to…
Halozyme Therapeutics Stock Down 8% on 2022, 2023 Revenue Guidance...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Halozyme Therapeutics Inc. HALO stock fell in the extended session Tuesday after the biotech drug maker’s 2023 forecast disappointed Wall…
2023 Total Revenue Guidance of $815 to $845 Million Representing >20% Growth Over Expected 2022 Revenue 2023 Recurring Revenues from…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Halozyme Therapeutics, Arista Networks and Citizens Financial Group have been highlighted in this Screen of The Week article....…
As 2023 approaches, its prudent to have a look at stocks like Halozyme Therapeutics (HALO), Arista Networks (ANET) & Citizens…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
NEW YORK, Dec. 19, 2022 /PRNewswire/ -- Epinephrine autoinjector market insights - Vendors: 15+, including Adamis Pharmaceuticals Corp., ALK Abello…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Latest Ratings for HALO
DateFirmActionFromTo Nov 2021Wells FargoMaintainsOverweight Nov 2021JMP SecuritiesMaintainsMarket Outperform Nov 2021SVB LeerinkMaintainsOutperform
…
Halozyme Therapeutics (HALO) delivered earnings and revenue surprises of 42.31% and 11.23%, respectively, for the quarter ended September 2022. Do…
Halozyme Therapeutics (HALO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings…